<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>continuous on KonFound-it!</title>
    <link>https://www.konfound-it.org/tags/continuous/</link>
    <description>Recent content in continuous on KonFound-it!</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2020. All rights reserved.</copyright>
    <lastBuildDate>Wed, 13 May 2020 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.konfound-it.org/tags/continuous/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>From early RCT: robust inference of Remdesivir effect on time to clinical improvement</title>
      <link>https://www.konfound-it.org/2020/05/13/remdesivir-on-time-to-clinical-improvement/</link>
      <pubDate>Wed, 13 May 2020 00:00:00 +0000</pubDate>
      <guid>https://www.konfound-it.org/2020/05/13/remdesivir-on-time-to-clinical-improvement/</guid>
      <description>Now consider the previous example of Remdesivir but instead we are interested in the continuous outcome variable of time to clinical improvement.&#xA;Figure 1. Time to clinical improvement in the Remdesivir example. Data from Table 3, Wang et al (2020).&#xA;We can interpret the robustness of inference regarding Remdesivirâ€™s effect on time to clinical improvement in following ways.&#xA;Percent bias necessary to invalidate the inference To invalidate an inference, \(70.</description>
    </item>
  </channel>
</rss>
